The pharmaceutical company's owners have agreed to pay US7.4 billion ($11.7 billion) and relinquish ownership of the company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback